IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-33968-5.html
   My bibliography  Save this article

Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer

Author

Listed:
  • Bihui Cao

    (the Second Affiliated Hospital of Guangzhou Medical University
    the Second Affiliated Hospital of Guangzhou Medical University)

  • Manting Liu

    (the Second Affiliated Hospital of Guangzhou Medical University
    the Second Affiliated Hospital of Guangzhou Medical University)

  • Lu Wang

    (the Second Affiliated Hospital of Guangzhou Medical University)

  • Kangshun Zhu

    (the Second Affiliated Hospital of Guangzhou Medical University)

  • Mingyue Cai

    (the Second Affiliated Hospital of Guangzhou Medical University)

  • Xiaopei Chen

    (the Second Affiliated Hospital of Guangzhou Medical University)

  • Yunfei Feng

    (the Second Affiliated Hospital of Guangzhou Medical University)

  • Shuo Yang

    (University of Macau
    Guangzhou Medical University)

  • Shengyu Fu

    (University of Macau)

  • Cheng Zhi

    (the Second Affiliated Hospital of Guangzhou Medical University)

  • Xiaodie Ye

    (the Second Affiliated Hospital of Guangzhou Medical University)

  • Jian Zhang

    (the Second Affiliated Hospital of Guangzhou Medical University)

  • Zhiru Zhang

    (the Second Affiliated Hospital of Guangzhou Medical University)

  • Xin Yang

    (the Second Affiliated Hospital of Guangzhou Medical University)

  • Ming Zhao

    (Cancer Center, Sun Yat-sen University)

  • Qingde Wu

    (Shunde Chinese Medicine Hospital, the Affiliated Hospital of Traditional Chinese Medicine University of Guangzhou)

  • Linfeng Xu

    (Sun Yat-sen University)

  • Lili Yang

    (Sun Yat-sen University)

  • Hui Lian

    (the Second Affiliated Hospital of Guangzhou Medical University)

  • Qi Zhao

    (University of Macau)

  • Zhenfeng Zhang

    (the Second Affiliated Hospital of Guangzhou Medical University
    the Second Affiliated Hospital of Guangzhou Medical University)

Abstract

The complex immunosuppressive tumour microenvironment (TME) and lack of tumour-specific targets hinder the application of chimeric antigen receptor (CAR) T cells in the treatment of solid tumours. Combining local treatment with CAR T cell immunotherapy may regulate the TME and enhance the killing potency of CAR T cells in solid tumours. Here, we show that AXL, which is highly expressed in non-small cell lung cancer (NSCLC) but not in normal tissues, might be a target for CAR T cell therapy. AXL-CAR T cells alone cause moderate tumour regression in subcutaneous and pulmonary metastatic lung cancer cell-derived xenograft models. Combination of microwave ablation (MWA) and AXL-CAR T cells have superior antitumour efficacy. MWA enhances the activation, infiltration, persistence and tumour suppressive properties of AXL-CAR T cells in AXL-positive NSCLC patient-derived xenograft tumours via TME remodelling. The combination therapy increases the mitochondrial oxidative metabolism of tumour-infiltrating CAR T cells. Combination treatment induces significant tumour suppression without observed toxicities in humanized immunocompetent mice. The synergistic therapeutic effect of MWA and AXL-CAR T cells may be valuable for NSCLC treatment.

Suggested Citation

  • Bihui Cao & Manting Liu & Lu Wang & Kangshun Zhu & Mingyue Cai & Xiaopei Chen & Yunfei Feng & Shuo Yang & Shengyu Fu & Cheng Zhi & Xiaodie Ye & Jian Zhang & Zhiru Zhang & Xin Yang & Ming Zhao & Qingde, 2022. "Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
  • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33968-5
    DOI: 10.1038/s41467-022-33968-5
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-33968-5
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-022-33968-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Yao Wang & Chuan Tong & Hanren Dai & Zhiqiang Wu & Xiao Han & Yelei Guo & Deyun Chen & Jianshu Wei & Dongdong Ti & Zongzhi Liu & Qian Mei & Xiang Li & Liang Dong & Jing Nie & Yajing Zhang & Weidong Ha, 2021. "Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming," Nature Communications, Nature, vol. 12(1), pages 1-18, December.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Xinyu Tang & Xinrui Mao & Peiwen Ling & Muxin Yu & Hua Pan & Jiaming Wang & Mingduo Liu & Hong Pan & Wen Qiu & Nan Che & Kai Zhang & Feifan Bao & Hongwei Peng & Qiang Ding & Shui Wang & Wenbin Zhou, 2024. "Glycolysis inhibition induces anti-tumor central memory CD8+T cell differentiation upon combination with microwave ablation therapy," Nature Communications, Nature, vol. 15(1), pages 1-20, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Maxine S. Y. Lam & Jose Antonio Reales-Calderon & Jin Rong Ow & Joey J. Y. Aw & Damien Tan & Ragavi Vijayakumar & Erica Ceccarello & Tommaso Tabaglio & Yan Ting Lim & Wang Loo Chien & Fritz Lai & Anth, 2023. "G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    2. Vipul Bhatia & Nikhil V. Kamat & Tiffany E. Pariva & Li-Ting Wu & Annabelle Tsao & Koichi Sasaki & Huiyun Sun & Gerardo Javier & Sam Nutt & Ilsa Coleman & Lauren Hitchcock & Ailin Zhang & Dmytro Rudoy, 2023. "Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-23, December.
    3. Fengqi Qiu & Peishan Jiang & Guiheng Zhang & Jie An & Kexin Ruan & Xiaowen Lyu & Jianya Zhou & Wanqiang Sheng, 2024. "Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells," Nature Communications, Nature, vol. 15(1), pages 1-17, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33968-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.